Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04699812 · ClinicalTrials.gov registry record · NA

Atrial Fibrillation Algorithms Clinical Validation Study

A NA study, sponsored by Apple.

Completed
Registry status
NA
Development phase
573
Enrollment target

NCT04699812 is a NA study that has completed, run by Apple. The registered enrollment target is 573 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04699812, a NA study, has completed, sponsored by Apple.

COMPLETED
Registry status
NA
Development phase
573 participants
Enrollment target

Study Summary

The purpose of the study is to evaluate the performances of investigational Irregular Rhythm Notification Feature (version 2.0) and Atrial Fibrillation History Feature algorithms.

Interventions

  • DEVICE ELECTROCARDIOGRAM (ECG) PATCH WEAR

Trial Details

FieldValue
Enrollment Target 573 participants
Start Date 2020-11-16
Est. Completion 2021-12-17
Phase NA

Sponsor

Apple

12 total trials

What the Registry Record Tells You About NCT04699812

The ClinicalTrials.gov registry entry for NCT04699812 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 573 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Apple, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which ELECTROCARDIOGRAM (ECG) PATCH WEAR is the first listed.

NCT04699812 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04699812 about?

NCT04699812 is a clinical study titled "Atrial Fibrillation Algorithms Clinical Validation Study". The purpose of the study is to evaluate the performances of investigational Irregular Rhythm Notification Feature (version 2.0) and Atrial Fibrillation History Feature algorithms.

What is the current status of trial NCT04699812?

This trial is currently completed. It is a NA study. The enrollment target is 573 participants. The study started on 2020-11-16. Estimated completion is 2021-12-17.

What interventions are being tested in trial NCT04699812?

The interventions under investigation include: ELECTROCARDIOGRAM (ECG) PATCH WEAR (DEVICE).

Who is sponsoring clinical trial NCT04699812?

This trial is sponsored by Apple, which has 12 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.